相关实验视频
Updated: Sep 15, 2025

06:18
High-Throughput Protein Crystallization via Microdialysis
Published on: March 3, 2023
2.5K
在接受血液透析的患者中估计T50蛋白结晶试验:大阪透析并发症研究 (ODCS)
Tetsuo Shoji1,2,3,4, Daijiro Kabata5, Yu Nagakura6
1Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, 545-8585, Japan. tetsuoshoji@omu.ac.jp.
Clinical and experimental nephrology
|July 17, 2025
概括
在T50蛋白结晶试验 (T50) 估计血清化阻力. 研究人员使用常见变量开发了估计T50 (eT50) 的方程,显示 eT50 预测了血液透析患者的心血管事件.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床化学 临床化学
- 生物标志物 生物标志物
背景情况:
- 蛋白结晶试验T50评估了血清对化的抵抗力.
- 由于T50测试的临床可用性有限,因此阻碍了其在慢性病 (CKD) 管理中的使用.
研究的目的:
- 使用现有临床变量开发估计T50 (eT50) 的预测方程.
- 评估eT50作为血液透析患者心血管事件预测指标的实用性.
主要方法:
- 一项涉及1651名血液透析患者的观察性研究.
- 使用测量T50和临床变量开发和验证三种回归模型 (A,B,C).
- 使用Akaike的信息标准进行变量选择.
主要成果:
- 导出了三个eT50方程,包括血清酸盐,,,,和总离子结合能力等变量.
- 所有模型在验证后都显示出良好的预测性能 (R2值在0.573到0.597之间).
- 所有模型预测的较低的ET50值,独立地与新心血管事件风险增加相关.
结论:
- 根据常规测量临床参数开发了估计T50 (eT50) 的三个不同的方程.
- 这些eT50方程为在无法直接测量T50时评估化倾向提供了可行的替代方案.
- eT50是血液透析患者心血管风险的有价值的独立预测指标.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
80
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
Acute Kidney Injury V: Interprofessional Care
46
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
46
Hemodialysis I: Introduction
305
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
305

